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당뇨병성족부궤양의 치료를 위한 고가 은
나노입자의 응용
Preparation of High Valence Silver Complex







당뇨병성 족부궤양(DFUs)은 당뇨병 환자의 건강에 심각한 영향을 미치는 당
뇨병의 주요 합병증 중 하나다. 상처치유는 DFUs의 치료에 필수적인 과정이다.
병원성 박테리아의 감염과 관련된 염증은 상처치유의 중요한 역동단계 중 하나다.
항생제는 DFUs에 널리 이용되고 있다. 항생제 내성으로 인해, 은이 함유된 항
균제가 더 큰 관심을 불러올 것이고 효과적일 것으로 보인다. 이 문제를 해결하기
위해 역마이크로 에멀젼 기술을 이용하여 더 높은 항균작용의 고가 은 나노입자를
설계하고 합성했다. 증식은 상처치유의 또 다른 필수단계다. 상처치유는 수선 및
세포성장을 위한 아미노산에 대한 요구를 증가시킨다. L-phenylalanine은 필수
아미노산 중 하나다. 즉, 인체에서 합성될 수 없고 음식물로 보충해야한다. 본 연
구에서는 은 복합체 합성에 리간드로 작용하는 L-phenylalanine을 함유하는
Boc-L-phenylalanine와 propamidine을 결합했다. 따라서 이 화합물은 아미노
산 부분을 포함함으로써 증식성 치료능력을 가진다. Silver (II)-Boc-propamidine
나노입자는 모두 분광기술로 측정했다. 우리는 DFUs의 병원균에 대항하는
silver(II)-Boc-propamidine 나노의 항균활성을 조사하였다. 새로 합성된 고가 은
II
복합체 나노입자가 은나노입자(AgNPs)보다 높은 항균활성을 나타났다. 이 연구는
합성된 silver(II)-Boc-propamidine 나노입자가 보다 우수한 항균활성을 입증한
다고 결론지었다. 당뇨병성 족부궤양의 치료를 위한 차세대 치료제로 사용될 수
있을 것이다.
주 요 어: Propamidine, Silver nanoparticle, 당뇨병족궤양, 항균, 증식
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Diabetes mellitus is a severe chronic disease worldwide1. The sharp rise in the
prevalence of diabetes leads to an increase in diabetes related complications2. Diabetic foot
ulcers (DFUs) is one of the main complications of diabetes mellitus, which seriously affects
the health of diabetic patients. Up to 15% to 25% of people suffer fromDFUs at some point
in all patients with diabetes mellitus3-4. DFUs has higher risk in amputation and mortality
rate. All chronic wounds are infected by microorganisms5. Wound healing is a dynamic
process containing collagen synthesis, inflammation, proliferation and tissue remodeling
four procedures6.
Patients with diabetic foot ulcers treated with antibiotics are often infected by
gram-positive bacteria and gram-negative bacteria7. Antimicrobial agents are widely
applied for the treatment of wounds in the presence of wound infection. Topical bactericide
can affect wound healing, but silver containing antimicrobial agents appear to be safe and
effective. Wound healing requires effective antimicrobial therapy as well as
re-epithelialization8.
People have known the antibacterial properties of silver for centuries around the
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world9. The use of silver as an antibacterial agent decreased after antibiotics were
discovered. Due to the emergence of antibiotic resistance, there has recently been renewed
interest in the use of silver as an antibacterial agent10. Although the antibacterial properties
of silver have been known for a long time, we have only recently begun to understand the
antibacterial mechanism of silver. The mechanism of action of silver is related with protein
deactivation that the silver atoms bind to the sulfhydryl groups in the enzyme, resulting in
the inactivation of the enzyme. Another mechanism is that silver ions released by silver
entering the cell and associatingwithDNA, thus causing bacterial cell damage11.
Silver nanoparticles particle size is less than 100nm, which are especially
advantageous as antibacterial agents in the field of wound healing. It can be applied to
antibacterial medicine and medical equipment, antibacterial plastic and rubber products.
The application of silver nanoparticles to increase the surface to volume ratio has been
reported to be successful in improving the bactericidal efficiency. Thus, an increase in the
contact area of nanoparticles is able to produce more silver ions capable of interacting with
bacteria, thereby impairing them through multiple pathways. For these reasons, silver
nanoparticles have received great attention in the field of wound care12. Silver has good
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antibacterial activity and moisturizing effect on human skin. Silver nanoparticles have great
potential for promoting the re-epithelialization of skin wounds as an ideal therapeutic agent
for the treatment of chronic wounds. The key issue is how to develop silver nanoparticles to
enhance the proliferation andmotility of skin cells.
In recent years, it has been demonstrated that high-valence silver showed stronger
antibacterial ability than low-valence silver 13. These findings have prompted us to attempt
to synthesize high valence silver complexes nanoparticles with both antibacterial ability and
re-epithelialization activity. Silver ions can form complexes with ligands in the oxidation
state of +1, +2, + 3. When ligands complexed with silver ions have auxiliary functions,
such as acceleration proliferation and viability, the silver complex can be expected to
possess a versatile therapeutic activity. We attempted to prepare high valance silver
complex nanoparticles with antibacterial and proliferative function to promote wound
healing.
Silver sulfadiazine was applied to prevent wound infection especially for burn wound
infection. Silver sulfadiazine is the standard drug for prevention and treatment of severe
burn infection. In addition to controlling infection, it can also promote healing. Silver
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sulfadiazine has a broad spectrum of antimicrobial activity against many gram negative and
gram positive bacteria. It has low toxicity, a broad spectrum of activity against a wide range
of microbial pathogens. Silver sulfadiazine can decompose to release silver and
sulfadiazine slowly when exposed to tissue14.The development of antimicrobial reagents
has achieved remarkable results 15. In view of the fact that silver sulfadiazine possess the
astringency effect of silver and the antibacterial and anti-inflammatory effects of
sulfadiazine, we attempt to prepare a novel silver containing bifunctional antibacterial
reagent for diabetic foot ulcers application.
Propamidine is one of the antibacterial agents that can inhibit the growth of
microorganisms, including bacteria, viruses, fungi as well as protozoans16. It is a type of
guanidine aromatic compounds for the treatment of ocular infections. Propamidine is an
aromatic diamidine compound, which can be used as a chelating ligand. This ligand with
silver can form silver complex which have the potential to be used as a new type of
antibacterial agent. Propamidine possess conjugate single and double bond systems and
filled with p-type delocalized orbitals suitable for the formation of higher valence silver
complexes. It has been shown that the guanidine compounds have been used for
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antibacterial and antifungal drugs for many years, such as polyhexamethylene guanidine
(PHMG), brolene and chlorhexidine. Silver chlorhexidine complex has been prepared
successfully to antibacterial field17. Therefore we choose propamidine as the ligand of silver
complex. In addition, the amine group in propamidine can be conjugated with amino acid
by peptide coupling reaction, thus this compoundwill possess the potential of proliferation.
The final result of the wound healing process is to repair the defective tissue.
Coagulation is an essential process for healing wounds. The goal of treatment is to enhance
collagen deposition in order to improve the strength and integrity of the wound. The
addition of nutrition can promote wound healing. The wound will increase the demand for
amino acids for the repair and cell growth. L-Phenylalanine is one of the essential amino
acids for the human body, which means that the body needs this component and cannot
produce it naturally18. N-(tert-Butoxycarbonyl)-L-phenylalanine (Boc-L-Phenylalanine)
is a derivative of phenylalanine can be used as amino acid protection monomers for
peptide coupling synthesis19.
In this study, we conjugated propamidine with Boc-L-phenylalanine which contain
phenylalanine moiety as a ligand. Then we synthesized high-valence silver complex
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nanoparticles by incorporating Boc-L-phenylalanine-propamidine (Boc-propamidine)
moiety using reverse microemulsion technique. The synthesized Ag(II)Pro-Boc
nanoparticles possess higher antibacterial activities against the tested gram positive and
negative strains responsible for diabetic foot ulcers. Besides, this compound also has the
potential proliferative therapeutic ability due to containing amino acid moiety. And it may




Silver nitrate, triethylamine, sodium persulfate, dioctyl sulfosuccinate (AOT), and
heptanes used for the synthesis of nanoparticles and
N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide, hydrochloride (EDC.HCl),
1-hydroxybenzotriazole hydrate (HOBT), N, N-diisopropylethylamine and hydrochloric
acid used for the synthesis of Boc-L-phenylalanine were purchased from Sigma-Aldrich,
South Korea. The propamidine was purchased from Stru Chem CO., LTD, China. We
bought sodium chloride and aluminumoxide, basic fromAlfaAesar, SouthKorea.
IR spectrum was obtained from the JASCO FT/IR-4200 spectrometer. Transmission
electron microscope (TEM) was recorded in JEM 3010 and JEM 1010, Jeol, Tokyo. The
UV-Vis absorption spectrumwas recorded in aThermoScientific Evolution 60 instrument.
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Figure1. Preparation Scheme for the Synthesis of Boc-Propamidine
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2. Synthesis of Boc-L-Phenylalanine-Propamidine
The synthetic scheme for the preparation of Boc-propamidine is shown in Figure 1.
The synthesis of Boc-L-phenylalanine-propamidine was performed by amine to amide
peptide coupling reaction20. We choose EDCI and HOBT as coupling reagent. The
synthesis of ligand was performed in dichloromethane:dimethylformamide (2:1) solvent
system. 0.8mmol Boc-L-Phenylalanine, EDC.HCl and HOBT was dissolved in 15ml
dichlormethane. The reaction mixture was stirred for 1 h at 0  C under nitrogen
environment. Then add the solution of 0.32mmol propamidine dissolved in 7.5ml
dimethylformamide to the mixture and use 0.5 ml N,N-Diisopropylethylamine (DIEA) to
activate reaction. The reaction was stirred at room temperature for 16h. After the reaction,
workup and purify the compounds by basic alumina column. The product was dried and
analyzed byMass spectroscopy, 1HNMRand FT-IR .
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Figure2. Preparation Scheme for theSynthesis ofAg(II)Pro-BocComplex
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3. Synthesis ofAg(II)Pro-BocComplex
The synthesis ofAg(II)Pro-Boc complex procedure is shown in figure 2. The complex
was synthesized in water: methanol (4:1) solvent system. BOC-Propamidine, AgNO3 and
sodium persulfate were used at a 2:1:1 molar ratio to form the complex. 0.2mmol of
BOC-Propamidine was first dissolved in solvent, followed by the pH of the reaction
mixture was adjusted by adding triethylamine. The reaction medium was stirred for 20
minnutes after adding 0.1 mmol AgNO3 solution. Before stirring the reaction mixture,
sodium persulfate solution was added. Reaction was stirred at room temperature for another
30 mins. Then the compound was filtered by vacuum filtration and washed with methanol
to remove the unreacted reagents and impurities. Dried the product and characterized it by
1HNMR,Mass spectroscopy, FT-IR andUVs.
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Silver complex nanoparticles were synthesized using a water in oil microemulsion
technique21. The synthesis of Ag(II)Pro-Boc complex nanoparticles procedure is shown in
figure 3. Briefly, the nanoparticles were prepared by dissolving 0.44g ofAOT (0.1M) in 10
ml of heptane, followed by addition of 90 µl Boc-Propamidine aqueous solution.
Afterwards, 90 µl of silver nitrate and 90 µl of sodium persulfate were added to the heptane
solution simultaneously. The pH of the reaction medium was adjusted by adding
triethylamine to form a stable microemulsion (pH=7.0). In this mixture reaction, silver
nitrate, Boc-Propamidine, and sodium peroxydisulfate were used at a 1:2:2 molar ratio to
form the complex. The reaction mixture was stirred at room temperature for 1 h and
microemulsion system turned brown which indicates higher valence silver state formed.
Then the reaction was stirred for 24 h at room temperature. To isolate nanoparticles ethanol
was used to break the microemulsion system. And nanoparticles were collceted by
centrifugation at 10000 rpm for 10 minutes. After centrifugation, the nanoparticles were
washed twice using methanol to remove the unreacted starting materials and impurities.
Finally, silver complex nanoparticles were dried by vacuum, collected and reserved at room
14
temperature.
5. Synthesis of SilverNanoparticles
20 nm of silver nanoparticles were synthesized according to the previously published
method22. Finally, the color of the solution changed to yellow. Cool the nanoparticles
solution to room temperature and centrifuge the suspensions at 12000 rpm for 15 minutes.
Then, wash the nanoparticles twice using the distilled water to remove the unreacted
starting materials and impurities. The products were characterized by TEM and UV-Vis
spectroscopy.
6.Transmission ElectronMicroscope (TEM)Analysis
The size and morphology of silver complex nanoparticles were measured using
transmission electron microscope (TEM). The sample for TEM characterization was
prepared by adding 10ul the nanoparticle-containing solution on 200-mesh carbon-coated
copper grids.Afterwards, keep it dry enough at room temperature for further analysis.
7. Characterization of Silver--Boc-Propamidine Complex
For Boc-Propamidine (ν, cm-1): 3326 (-CONH-), 1680 (C=N, m) and 1607(C=C),
1497(-CH2) 1251(C-N). For Ag(II)Pro-Boc Nano (ν, cm-1): 3320 (-CONH-), 1605 (C=C),
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2348 (C-N,m), 1507(-CH2),1259(C-N ).
8. Bacterial Strains andCultureCondition
The tested organism strains include three strains of gram-positive bacteria
(Staphylococcus aureus [ATCC 25923], Enterococcus faecalis [ATCC 29212],
Streptococcus agalactiae [ATCC 12386]) and three strains of gram-negative bacteria
(Pseudomonas aeruginosa [ATCC 27853], Klebsiella pneumonia [ATCC 10031],
Acinetobacter calcoaceticus [ATCC 23005] ). Six strains of organism were obtained from
American Type Culture Collection (Rockville MD, USA). All tests were performed in
accordance with the Clinical and Laboratory Standards Institute guidelines. The six
bacterial strains were cultured overnight for the purpose of inoculation. The strains were
grown in Muller Hinton Broth or Muller Hinton Agar (MHB, MHA, Difco Laboratories,
Detroit,MI,USA) at 37 C under aerobic conditions.
9.Determination ofMICs andMBCs
Minimum inhibitory concentrations (MICs) were determined by broth microdilution
method in Muller Hinton Broth (MHB) for six bacterial strains using Multi-Reader
(Molecular Devices, Spectra MAX M5). 96 well microplates were read after 24h
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incubation at 37 C under aerobic condition. Organism strains were cultured in 96 well
microplate. In order to evaluate the inhibitory effect of antimicrobial agents on bacterial
growth, each well was provided with different concentrations of antimicrobial agents.
Microbial growth was examined following 24 h incubation in air at 37 C, and MICs was
defined as minimum concentration of antimicrobial agents to prevent bacterial growth. The
effect of coagulation was also determined in the uninoculated group. The minimum
bactericidal concentrations (MBCs) were determined by the reinoculation from wells onto
empty Muller Hinton Agar plates. After 24 h incubation, the MBCs was defined as the
lowest concentration that no bacteria growth was observed on the agar plates. All tests were
performed in triplicate. The determination of MICs and MBCs is based on the guidelines




The synthesis of high valence silver-Boc-propamidine complex nanoparticles is
shown in Figure 3. The main step is to determine the appropriate solvent medium.
Ag(II)Pro-Boc complex was synthesized under different solvent conditions. Initially, we
attempted different solvent conditions such as dimethyl sulfoxide (DMSO), water, and
methanol in the process of synthesis. Equal and different proportions of solvents were also
examined. Finally, we successfully performed the reaction in water:methanol (4:1) solvent
system.We aquired high valence silver complex using sodium peroxysulfate to oxidize the
silver ion. Triethylamine was added to a neutral homogeneous microemulsion medium for
complexation reaction. Under neutral conditions (pH = 7) to maintain an appropriate
medium for 24 h to achieve fine and uniform size of nanoparticles.
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Figure4. (a) ESI-Mass Spectra for Boc-Propamidine; (b)ESI-Mass Spectra for Ag(II)Pro-Boc; (c)
UV-Vis Spectra of Boc-Propamidine (black) and Synthesized Ag(II)Pro-Boc Nanoparticles (red);
(d) IRSpectra ofBoc-Propamidine (red) and synthesizedAg(II)Pro-BocNanoparticles ( black)
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2. Charecterization ofAg(II)Pro-BocNanoparticles
Figure4.a and Figure4.b show the ESI-MS of synthesized Boc-propamidine and
Ag(II)Pro-Boc nanoparticles. ESI-MS confirmed the formation of Boc-propamidine
(C45H54N6O8, m/z: 807). Moreover, the silver and Boc-propamidine complex formation
was vertified by ESI-MS spectrum. The fragmented mass of Ag(II)Pro-Boc was observed
at 913 (C45H53AgN6O8=913 g/mol). The UV absorption spectroscopy is commonly used to
characterize the nanoparticles. The absorption pattern of Ag(II)Pro-Boc nanoparticle is
different from the starting material Boc-Propamidine ligand. The Ag(II)Pro-Boc
nanoparticles showed strong absorption peak at 270 nm with characteristic peaks at 320nm
as shoulder peaks (Figure4.c). FT-IR Spectrum of Ag(II)Pro-Boc complex are shown in
Figure4.d The band at 3320 and 3028 cm-1 appeared in IR spectrum are the characteristic
broad peaks of amide (-CONH-) and imine( =NH) of the starting material
Boc-propamidine. In the IR spectra of the compound (Ag(II)Pro-Boc), this broad imine
band disappearedwhich clearly indicated the formation of the complex (Figure4.d).
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Figure5. (a) TEM Images of Ag(II)Pro-Boc Nanoparticles Synthesized at Different
Water-to-Surfactant Molar Ratios (R = 8, 10, 12.4 and 15). Scale bar is 100 nm; (b) Size Distribution
and theAverage Diameters ofAg(II)Pro-Boc Nanoparticles at Various R Values (8, 10, 12.4 and 15 are
13.6, 16.8, 10.6 and 8.9 nm, respectively).
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For the synthesis of Ag(II)Pro-Boc nanoparticle, we applied a microemulsion
composition containing water / AOT / heptane ternary system. The molar ratio of various
water to surfactant (R) is 8, 10, 12.4, 15 respectively. Figure 5.a and Figure5.b show the
transmission electron microscopy (TEM) image and the size distribution of the
Ag(II)Pro-Boc nanoparticles prepared at different R values. TEM images demonstrate that
the particles exhibit a monodisperse spherical morphology whose initial size increases and
then decreases corresponding to an increase inR value.
The diameter mean size is 13.6 nm for R = 8, and average particle diameter increased
to 16.8 nm , at R = 10. There is a continuous reduction in the mean size to 10.6 nm for R =
12.4 and 8.9 nm for R = 15. On the whole, the size of the nanoparticles increases with the
increasing of R value, which means the amount of water droplets in microemulsion. Thus,
the increase in the mean sizes of Ag(II)Pro-Boc nanoparticles with the increase in R value
from 8 to 10. However, the mean size of the nanoparticles reduced when R value is 12.We
observed that as the diameter of the microemulsion increases the average particle size
decreases further when R value is 15. From these results it can be seen that the
microemulsion droplets provide a limited microenvironment while other parameters may
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play a critical role in influencing the sizes of theAg(II)Pro-Boc nanoparticles formed in the
microemulsion5.
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Figure6. The Minimal Inhibitory Concentrations (MICs) were Determined by Measuring the
OpticalDensityUsingMulti-PlateReader.
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Figure7. After Measuring the Optical Density, Minimum Bactericidal Concentrations (MBCs)
were Determined by the Reinoculation Gram negative/ Positive strains (a, b, c, d, e, f) fromWells
onto Empty Muller Hinton Agar(MHA), Supplemented with Different Concentrations of
Ag(II)Pro-BocNanoparticles, fromLeft toRight Control 1, 2, 4, 8 µM.
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3.Antibacterial activities ofAg(II)Pro-Boc nanoparticles
We tested the antibacterial activities of the Ag(II)Pro-Boc nanoparticles toward
gram-positive and gram-negative responsible microorganism strains for the DFUs.
Determination of minimal inhibitory concentrations (MICs) is a standard microbiological
technique for the evaluation of antimicrobial activity. MICs were defined as lowest
concentration of antimicrobial agents to inhibit visible bacterial growth after 24h incubation.
The MICs values presented in Table were determined using a broth microdilution method.
The minimum bactericidal concentrations (MBCs) were determined by the reinoculation
from wells to empty Muller Hinton agar (MHA) plates. The MBCs was defined as the
lowest concentration that no bacteria growth was observed on the agar plates after 24 h
incubation. The MBCs values were determined to evaluate the bactericidal properties of
Ag(II)Pro-Boc nanoparticles.
The MICs results after measuring the optical density through the use of 96 well
multi-microplate reader were shown in Figure6. From the data, the synthesized
Ag(II)Pro-Boc nanoparticles has the best inhibitory effect on all strains. The MICs values
ofAg(II)Pro-Boc nanoparticles were in the range of 4 μ M according to the optical density.
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These results indicate that there is no difference in MIC values between gram positive and
gram negative bacteria. For MBCs values, apart from the MBCs of enterococcus faecalis
and streptococcus agalactiae are 4 μM, the other strainsMBCs all are 8 μM(Figure7).
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Figure 8. (a)VisualObservation of SynthesizedAgNPs (left) before and (right) afterAddition of
Reducing Agent, theColor Changes toYellow; (b)UV-Vis Spectra ofAgNPs; (c)TEMImage ,
Scale bar is 50nm ;(d) Particle SizeDistribution ofAgNPs.
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4. Comparison of Antibacterial Activities between Ag(II)Pro-Boc
Nanoparticles and SilverNanoparticles
We compared antibacterial activities betweenAg(II)Pro-Boc and silver nanoparticles
with similar particles size distribution. The UV-Vis absorption spectra and TEM ofAgNPs
as well as size distributions were shown in figure8. The TEM and size distribution study
confirmed that they were in same size distribution. The values of MICs and MBCs the
Ag(II)Pro-Boc nanoparticles and silver-only nanoparticles were determined. The results
was shown in Table 1.As shown in the results, the antibacterial activities ofAg(II)Pro-Boc















4 8 20 40
Pseudomonas
aeruginosa
4 8 40 40
Acinetobacter
calcoaceticus
4 8 20 40
Staphylococcus
aureus
4 8 40 80
Enterococcus
faecalis
4 4 40 40
Streptococcus
agalactiae
4 4 20 40
Table1. Antibacterial Activity of Synthesized Ag(II)Pro-Boc Nanoparticles and Silver-Only
Nanoparticles against Pathogens ofDiabetic FootUlcers.
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Ⅳ. Conclusions
In this study, we synthesized silver(II) Boc-propamidine nanoparticles by reverse
microemulsion method and it has been characterized by spectroscopic techniques. We
determined the antimicrobial activity of silver(II) Boc-propamidine nanoparticles against
both gram-positive and gram-negative pathogenic bacteria of diabetic foot ulcers.
Compared to silver nanoparticles, Ag(II)Pro-Boc nanoparticles show a more favorable
antibacterial effect. Because of its stability, uniformdispersity and high antibacterial activity,
these nanoparticles are expected to become the next generation of topical antimicrobial
agents for the diabetic foot ulcers care.
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Diabetic foot ulcers(DFUs) is one of the main complications of diabetes mellitus,
which seriously affects the health of diabetic patients.Wound healing is an essential process
in the treatment of DFUs. The inflammatorywith the infection of pathogenic bacteria is one
of the important dynamic phases in wound healing. Antibiotics has found a widely
utilization in DFUs. Due to antibiotic resistance, silver containing antimicrobial agents
deserve greater attention and appear to be effective. To address this problem, we designed
and synthesized the high valence silver complex nanoparticles using reverse microemulsion
technique for its higher antibacterial ability. Proliferation is another essential step in the
wound healing.Wound healing increases the requirement for amino acids for repair and cell
growth. L-Phenylalanine is one of the essential amino acids, which means it cannot be
synthesized in the human body and must be supplemented by diet. In this study, we
conjugate propamidine with Boc-L-phenylalanine which contain L-phenylalanine moiety
as a ligand for the silver complex synthesis. Thus, this compound possesses the proliferative
potential therapeutic ability due to containing amino acid moiety.
Silver(II)-Boc-propamidine nanoparticles have been characterized by spectroscopic
35
techniques. Up to now, we investigated the antibacterial activity of
silver(II)-Boc-propamidine nanoparticle against pathogens of DFUs. The newly
synthesized high valence silver complex nanoparticles demonstrate better antibacterial
activity compared to silver nanoparticles (AgNPs). This study concludes the synthesized
silver(II)-Boc-propamidine nanoparticles show better antibacterial ability. And it may serve
as next generation therapeutic agent for the treatment of diabetic foot ulcers.
Key words: Propamidine, Silver Nanoparticle, Diabetic foot ulcers, Antibacterial,
Proliferation.
